Stratec SE
XETRA:SBS

Watchlist Manager
Stratec SE Logo
Stratec SE
XETRA:SBS
Watchlist
Price: 25.5 EUR 1.19%
Market Cap: 310.1m EUR

SBS's latest stock split occurred on Jul 31, 2006

The company executed a 2-for-1 stock split, meaning that for every share held, investors received 2 new shares.

The adjusted shares began trading on Jul 31, 2006. This was SBS's 2nd stock split, following the previous one in Oct 11, 2000.

Last Splits:
Jul 31, 2006
2-for-1
Oct 11, 2000
3-for-1
Pre-Split Price
N/A
Post-Split Price
26.6796
Before
After
Last Splits:
Jul 31, 2006
2-for-1
Oct 11, 2000
3-for-1

Stratec SE
Stock Splits History

SBS Stock Splits Timeline
Jul 31, 2006
Jul 31, 2006
Split 2-for-1
x2
Pre-Split Price
N/A
Post-Split Price
26.6796
Before
After
Oct 11, 2000
Oct 11, 2000
Split 3-for-1
x3
Pre-Split Price
N/A
Post-Split Price
26.6796
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Apr 22, 2025
Seres Therapeutics Inc
SWB:1S9
1-for-20
/20
0.3216 6.432 EUR 6.432 6.432 EUR
Apr 22, 2025
G
Golden Shield Resources Inc
F:4LE0
1-for-10
/10
0.011 0.11 EUR 0.11 0.11 EUR
Apr 22, 2025
E
EV Advanced Material Co Ltd
KOSDAQ:131400
911-for-787
x1.1575603557814
1493 1493 KRW 1439 1439 KRW
Apr 22, 2025
Seres Therapeutics Inc
F:1S9
1-for-20
/20
0.01 0.2 EUR 0.2 0.2 EUR
Apr 22, 2025
G
Golden Shield Resources Inc
OTC:GSRFF
1-for-10
/10
0.024 0.24 USD 0.24 0.24 USD
Load More

Stratec SE
Glance View

Market Cap
310m EUR
Industry
Health Care

STRATEC SE engages in the design and manufacture of automated analyzer systems in the fields of clinical diagnostic and biotechnology. The company is headquartered in Birkenfeld, Baden-Wuerttemberg and currently employs 1,398 full-time employees. Its business activities are divided into three segments: Instrumentation, which designs and manufactures fully automated analyzer systems for its clinical diagnostics and biotechnology customers; Diatron, which offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications, and Consumables, which develops and sells scientific materials, such as nucleic acid purification and designs and produces smart consumables in the fields of diagnostics, life sciences, and medical technology. In addition, the Company develops workflow software for networking various analyzer systems, as well as develops and sells scientific materials and technologies.

SBS Intrinsic Value
51.86 EUR
Undervaluation 51%
Intrinsic Value
Price
Back to Top